Toshiyuki Harada

10.5k citations
132 papers · 3.4k indexed · 2 hit papers · h-index 29
    • Lung Cancer Treatments and Mutations 53
    • Lung Cancer Diagnosis and Treatment 16
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 11
    • Gastric Cancer Management and Outcomes 9
  • Radiation top 1%
  • Oncology top 2%
    • Lung Cancer Research Studies 37
    • Colorectal Cancer Treatments and Studies 17
    • Cancer Immunotherapy and Biomarkers 9
    • Gastrointestinal motility and disorders 9

Toshiyuki Harada

128 papers receiving 3.4k citations

Hit Papers

Gefitinib Alone Versus Gefitinib Plus Chemo...3452012202620162021100200300400

Peers

Toshiyuki Harada
Comparison fields: 5 of 122
  • Pulmonary and Respiratory Medicine 2.0k
  • Radiation 467
  • Oncology 1.4k
  • Gastroenterology 177
  • Microbiology 20
Replace Luka Brčić with:
Luka Brčić Austria
James A. Radosevich United States
George Theodoropoulos Greece
Geoffrey B. Johnson United States
Michael Schwarz Germany
Taku Nakagawa Japan
Shuji Bandoh Japan
Eyal Fenig Israel
Keiji Koda Japan
A. R. Moossa United States
Toshiyuki Harada relative to Luka Brčić Austria Luka Brčić's profile →
Citations per field
00.5×11.4×
Luka Brčić · 1×
Citations per year

Countries citing papers authored by Toshiyuki Harada

Since Specialization
Citations

This map shows the geographic impact of Toshiyuki Harada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiyuki Harada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiyuki Harada more than expected).

Fields of papers citing papers by Toshiyuki Harada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshiyuki Harada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiyuki Harada. The network helps show where Toshiyuki Harada may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Toshiyuki Harada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Toshiyuki Harada Line = papers co-authored together Toshiyuki Harada links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20234
3 20232
4 20231
5 202313
6 20231
7 202253
8 202219
9 20221
10 20204
11 201915
12 20192
13 201910
14 20177
15 2012131
16
Insect cell-based high-throughput screening systems for the identification of compounds with ecdysteroid mimetic insecticide activities
20071
17 200422
18 2002114
19 20001
20 20001

About Toshiyuki Harada

Toshiyuki Harada is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Gastroenterology, having authored 132 papers that have together received 3.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (53 papers), Lung Cancer Research Studies (37 papers), Colorectal Cancer Treatments and Studies (17 papers), Lung Cancer Diagnosis and Treatment (16 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers), Gastric Cancer Management and Outcomes (9 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Gastrointestinal motility and disorders (9 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.0k citations), Radiation (467 citations) and Oncology (1.4k citations). Toshiyuki Harada has collaborated with scholars based in Japan, Greece and United States. Frequent co-authors include Akira Inoue, Satoshi Morita, Kunihiko Kobayashi, Satoshi Oizumi, Shunichi Sugawara, Akihiko Gemma, Hirotoshi Dosaka‐Akita, Koichi Hagiwara, Koichi Yamazaki and Yuka Fujita. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026